Online FirstMore>
Articles in press have been peer-reviewed and accepted, which are not yet assigned to volumes /issues, but are citable by Digital Object Identifier (DOI).
Display Method:
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202605002
Abstract:
Objective To systematically evaluate the efficacy of topical traditional Chinese medicine (TCM) ointments in treating urticaria and to analyze their Therapeutic value. Methods Computerized searches were conducted in Chinese and English databases such as CNKI, Wanfang, VIP, PubMed, Cochrane Library, and EMbase. Relevant randomized controlled trials (RCTs) were manually extracted. The search period was from the establishment of the databases to December 2025. Two researchers independently screened the literature, extracted data, and used the Cochrane RoB 2.0 tool to assess the risk of bias in the included studies. The GRADE system was used for evaluating the quality of evidence. Meta-analysis was performed using RevMan 5.4 software. Results A total of 9 RCTs were included, involving 828 patients, predominantly pediatric patients with papular urticaria. The meta-analysis results showed that compared with conventional treatment interventions, the topical TCM ointment had significant advantages in improving the cure rate [RR=1.33, 95% CI(1.17, 1.51), P < 0.01], total effective rate [RR=1.09, 95% CI(1.04, 1.14), P<0.01], and the incidence of adverse reactions [RR=0.29, 95% CI(0.11, 0.76), P=0.01] of patients with urticaria. Subgroup analysis showed that this advantage existed in different intervention combinations and control formulations. The adverse reactions reported in the included studies were mild and transient, and some studies did not report obvious adverse reactions. Conclusion Based on the current evidence, the topical TCM ointment for treating urticaria shows significant advantages over conventional treatment interventions in improving the clinical improvement rate and cure rate, and has good safety. This supports the important position and application prospects of this Chinese herbal formulation in the treatment of pediatric papular urticaria, providing evidence-based references for rational and effective clinical medication and the development of topical preparations.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202603035
Abstract:
Objective To systematically evaluate the causal association between meningioma and asthma using a two-sample bidirectional Mendelian randomization (MR) approach. Methods Genome-wide association study (GWAS) data were used to select single nucleotide polymorphisms (SNPs) associated with meningioma and asthma as instrumental variables, respectively. The inverse variance weighted (IVW) method was applied as the primary analytical approach. Causal effects were quantified using odds ratios (OR) and 95% confidence intervals (95%CI). Heterogeneity among instrumental variables was assessed by Cochran's Q test, horizontal pleiotropy was examined using the MR-Egger regression intercept test, and sensitivity analyses were performed using leave-one-out validation. A funnel plot was used to visually evaluate the symmetry of effect estimates across SNPs. Results IVW analysis indicated a positive causal effect of meningioma on the risk of asthma (OR= 1.15,95%CI:1.10–1.20, P<0.05). Heterogeneity tests showed no significant heterogeneity among the selected SNPs (IVW Q-test P = 0.34; MR-Egger Q-test P = 0.82). The MR-Egger intercept test revealed no horizontal pleiotropy (P>0.05). Leave-one-out sensitivity analysis suggested that no single SNP substantially influenced the overall estimate, and the funnel plot showed symmetric distribution of SNP effects, supporting robust and reliable results. Reverse-direction MR found no statistically significant causal effect of asthma on meningioma risk (OR= 0.93, 95%CI: 0.80–1.09, P=0.36). Conclusion This two-sample bidirectional MR study provides evidence that meningioma may be an independent causal risk factor for an increased risk of asthma, whereas asthma shows no significant causal effect on meningioma risk, thus not supporting the existence of a reverse causal relationship.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202510037
Abstract:
Objective To explore the impact of medication therapy management (MTM) on medication adherence, medication knowledge, and incidence of adverse drug reactions (ADRs) in patients with coronary heart disease (CHD). Methods The Morisky Medication Adherence Scale and the Medication Knowledge Assessment Scale were established. Sixty patients with CHD who received pharmaceutical outpatient services from October 2023 to March 2025 were selected and divided into the MTM group and the control group using a random number table method, with 30 patients in each group. The control group received routine pharmaceutical outpatient counseling and conventional treatment, the MTM group received clinical pharmacist-led MTM services in addition to routine pharmaceutical outpatient counseling and conventional treatment. Analyze the medication adherence, medication cognition, and incidence of adverse reactions of the two groups of patients before and after the intervention at 0 months, 1 month, and 6 months, respectively. Results After 6 months, the medication adherence and medication knowledge in the MTM group were 7.20±0.43, 17.92±0.73 respectively, which were significantly higher than those in the control group (4.83±0.83, 11.20±1.55, respectively). The incidence of ADRs in the MTM group was 16.67%, which was significantly lower than those in the control group(43.33%). The differences were statistically significant (P<0.05). Conclusion MTM could significantly improve medication adherence and medication knowledge in patients with CHD, reduce the incidence of ADRs, and enhance the safety and efficacy of medication use for patients.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202210036
Abstract:
With the aging of the population, Alzheimer's disease(AD)has become a common disease in the elderly. Because of its complex pathogenesis and the limited clinical drugs which can only improve the symptoms, traditional Chinese medicine(TCM)shows great potential in the prevention and treatment of AD. Its multi-component and multi-target characteristics coincide with the network pharmacology's emphasis on multi-channel regulation of signal pathways. This paper summarized the common websites and tools of network pharmacology, as well as the application of network pharmacology in the research of AD, and provided reference for further research on the prevention and treatment of AD using traditional Chinese medicine.
With the aging of the population, Alzheimer's disease(AD)has become a common disease in the elderly. Because of its complex pathogenesis and the limited clinical drugs which can only improve the symptoms, traditional Chinese medicine(TCM)shows great potential in the prevention and treatment of AD. Its multi-component and multi-target characteristics coincide with the network pharmacology's emphasis on multi-channel regulation of signal pathways. This paper summarized the common websites and tools of network pharmacology, as well as the application of network pharmacology in the research of AD, and provided reference for further research on the prevention and treatment of AD using traditional Chinese medicine.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202603024
Abstract:
Objective To investigate the clinical recognition, anticoagulation transition strategies, and key points of pharmaceutical care for heparin-induced thrombocytopenia type II (HIT) in hemodialysis patients and provide reference for standardized management of similar cases. Methods Through a case report of a 78-year-old female patient with stage 5D chronic kidney disease (CKD) who developed type II HIT following low molecular weight heparin (LMWH) anticoagulation, clinical pharmacists participated in therapeutic decision-making. Clinical probability was assessed using the 4T's score, a heparin-free alternative anticoagulation regimen was formulated, and comprehensive pharmaceutical care was implemented throughout the treatment course. Relevant literature was reviewed to analyze pathogenesis, diagnostic criteria, and alternative anticoagulant options for HIT. Results The patient with end-stage renal disease (ESRD) underwent hemodialysis and developed progressive thrombocytopenia on day 11 of LMWH anticoagulation, accompanied by multiple deep veins thromboses (DVT) and dry gangrene of the extremities. Despite negative heparin-platelet factor 4 (PF4) antibody testing, the 4T's score was 7 points (high clinical probability). Clinical pharmacists recommended immediate discontinuation of all heparin and transition to Argatroban combined with Rivaroxaban. Following treatment, platelet counts progressively recovered, DVT resolved, and peripheral perfusion improved. Occult blood in stool and generalized ecchymosis occurred during therapy; bleeding manifestations resolved after rivaroxaban dose adjustment. Conclusion Hemodialysis patients are a high-risk population for type II HIT . For patients with 4T's score ≥6, immediate HIT management should be initiated regardless of antibody test results, including discontinuation of all heparin agents and initiation of non-heparin anticoagulation. Through participation in therapeutic decision-making, optimization of anticoagulation regimens, and adverse reaction monitoring, clinical pharmacists can effectively ensure medication safety in hemodialysis patients complicated with HIT.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202505038
Abstract:
Colchicine, a classic anti-inflammatory agent, has long been used for the prevention and treatment of gouty arthritis and familial Mediterranean fever. Given the pivotal role of inflammation in the development and progression of cardiovascular diseases, the clinical value of colchicine in the secondary prevention of cardiovascular diseases has attracted significant attention. Diabetes mellitus (DM) induces severe and irreversible vascular complications, among which cardiovascular diseases represent the leading cause of mortality in diabetic patients. However, existing research indicates heterogeneity in the therapeutic efficacy of colchicine among patients with cardiovascular diseases and those with diabetes complicated by cardiovascular conditions. The heterogeneity manifests as differences in efficacy across various disease stages, patient baseline characteristics, specific cardiovascular event types, endpoint definitions, and treatment regimens. The current domestic and international research findings on colchicine in relation to cardiovascular events and cardiovascular events in diabetic patients were reviewed in this paper, which aimed to elucidate the underlying causes of this efficacy heterogeneity and provided evidence-based guidance and reference for the precise identification of potential beneficiary populations and the optimization of individualized treatment strategies in clinical practice.
Colchicine, a classic anti-inflammatory agent, has long been used for the prevention and treatment of gouty arthritis and familial Mediterranean fever. Given the pivotal role of inflammation in the development and progression of cardiovascular diseases, the clinical value of colchicine in the secondary prevention of cardiovascular diseases has attracted significant attention. Diabetes mellitus (DM) induces severe and irreversible vascular complications, among which cardiovascular diseases represent the leading cause of mortality in diabetic patients. However, existing research indicates heterogeneity in the therapeutic efficacy of colchicine among patients with cardiovascular diseases and those with diabetes complicated by cardiovascular conditions. The heterogeneity manifests as differences in efficacy across various disease stages, patient baseline characteristics, specific cardiovascular event types, endpoint definitions, and treatment regimens. The current domestic and international research findings on colchicine in relation to cardiovascular events and cardiovascular events in diabetic patients were reviewed in this paper, which aimed to elucidate the underlying causes of this efficacy heterogeneity and provided evidence-based guidance and reference for the precise identification of potential beneficiary populations and the optimization of individualized treatment strategies in clinical practice.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202512033
Abstract:
Objective To systematically evaluate the efficacy of once-weekly tirzepatide in participants with obesity. Methods We searched PubMed, Cochrane Library, Embase, and The ClinicalTrails.gov identify randomized controlled trials comparing the efficacy and safety of Tirzepatide with placebo in adults with obesity, and searched the databases up to July, 2025. The quality of literature was evaluated after they were screened according to inclusion and exclusion criteria. The Meta-analysis analyses were conducted by using RevMan 5.3 and R 4.4.2 software, and analyzed the efficacy with different dose. Results This study included 11 articles, with 7570 obesity participants. The Meta-analysis results showed that with the dose growing up, tirzepatide is more effective in weight loss, waist circumference loss, body mass index loss, achievement of ≥5%, ≥10% and ≥15% weight loss comparing with placebo. Gastrointestinal side effects were common but generally mild. Conclusion Once-a-week tirzepatide appears to be effective and generally well-tolerated in adults with overweight or obesity.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202509041
Abstract:
As a traditional Chinese medicine, elemental sulfur has long been used for the treatment of scabies and tinea. In recent years, with the in-depth study of the biological function of elemental sulfur, its function has been extended to the treatment of acne, eczema, rosacea and other skin diseases, and the various mechanisms of elemental sulfur involved in the prevention and treatment of skin diseases are gradually being elucidated: the dual regulatory effect of elemental sulfur on skin keratinization, anti-inflammatory effect, antibacterial effect, and insecticide-killing effect. However, the therapeutic effects and specific mechanisms of action of this drug vary in different diseases, and the related research still need to be improved. In addition, the effects of elemental sulfur on pharmacokinetics and skin healing need to be further explored. The application status and mechanism of elemental sulfur in common skin diseases were systematically reviewed in this paper, which and provided a new perspective for the future development of elemental sulfur in the prevention and treatment of skin diseases.
As a traditional Chinese medicine, elemental sulfur has long been used for the treatment of scabies and tinea. In recent years, with the in-depth study of the biological function of elemental sulfur, its function has been extended to the treatment of acne, eczema, rosacea and other skin diseases, and the various mechanisms of elemental sulfur involved in the prevention and treatment of skin diseases are gradually being elucidated: the dual regulatory effect of elemental sulfur on skin keratinization, anti-inflammatory effect, antibacterial effect, and insecticide-killing effect. However, the therapeutic effects and specific mechanisms of action of this drug vary in different diseases, and the related research still need to be improved. In addition, the effects of elemental sulfur on pharmacokinetics and skin healing need to be further explored. The application status and mechanism of elemental sulfur in common skin diseases were systematically reviewed in this paper, which and provided a new perspective for the future development of elemental sulfur in the prevention and treatment of skin diseases.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202410049
Abstract:
Objective To compare the contents of malonyl-ginsenosides Rb3 (MG-Rb3) in different parts, including roots, stems, leaves and flowers, of Panax ginseng, P. quinquefolium and P. notoginseng. To explore the effects of two drying methods, constant temperature drying and vacuum freeze drying on their contents. Methods The contents of MG-Rb3 in P. ginseng, P. quinquefolium and P. notoginseng were compared based on HPLC analysis, using enzymatically synthesized MG-Rb3 as the reference standard. Results The buds of P. ginseng and P. quinquefolium exhibited relatively high levels of MG-Rb3, which were approximately 7.3-18.1 times and 2.8-4.3 times higher than those found in the roots, respectively, and the lowest contents were detected in the stems. The content of MG-Rb3 in P. notoginseng flower buds was about 31.2 times higher than that in leaves. The content of MG-Rb3 in the buds treated by constant temperature drying was about 1-1.1 times that of using vacuum freeze drying. Conclusion The highest content of MG-Rb3 was detected in the flower buds of P. ginseng and P. notoginseng, and the content of MG-Rb3 in leaves of P. quinquefolium was the highest. Content of MG-Rb3 in the buds after constant temperature drying was slightly higher than that of using vacuum freeze drying.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202509026
Abstract:
Alzheimer’s disease (AD) is a typical neurodegenerative disorder, and its pathogenic mechanism remains to be fully elucidated. Currently, there are limited drugs available for the clinical treatment of AD, and many of these drugs are associated with numerous adverse effects. Traditional Chinese medicine (TCM), featuring multi-component and multi-target properties, possesses unique advantages and potential in the prevention and treatment of AD. AD cell models enable in-depth investigations into the pathogenesis of AD and the mechanisms underlying drug-based prevention and treatment. Cell metabolomics studies changes in intracellular metabolites to accurately capture dynamic variations in metabolite types, contents, and metabolic pathways of cells under different physiological states; this approach holds promise for revealing the complex regulatory mechanisms of cellular metabolic networks, identifying AD-specific biomarkers, and providing support for research on the mechanisms of AD. This article reviews the drugs used for AD prevention and treatment, as well as recent progress in the application of cellular metabolomics in AD research, aiming to provide a reference for studies on AD mechanisms, clinical diagnosis and treatment, and drug development.
Alzheimer’s disease (AD) is a typical neurodegenerative disorder, and its pathogenic mechanism remains to be fully elucidated. Currently, there are limited drugs available for the clinical treatment of AD, and many of these drugs are associated with numerous adverse effects. Traditional Chinese medicine (TCM), featuring multi-component and multi-target properties, possesses unique advantages and potential in the prevention and treatment of AD. AD cell models enable in-depth investigations into the pathogenesis of AD and the mechanisms underlying drug-based prevention and treatment. Cell metabolomics studies changes in intracellular metabolites to accurately capture dynamic variations in metabolite types, contents, and metabolic pathways of cells under different physiological states; this approach holds promise for revealing the complex regulatory mechanisms of cellular metabolic networks, identifying AD-specific biomarkers, and providing support for research on the mechanisms of AD. This article reviews the drugs used for AD prevention and treatment, as well as recent progress in the application of cellular metabolomics in AD research, aiming to provide a reference for studies on AD mechanisms, clinical diagnosis and treatment, and drug development.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202508024
Abstract:
Objective To investigate the efficacy of aerobic exercise combined with sertraline in the treatment of post-stroke depression (PSD) in elderly patients and its effects on cognitive function and inflammatory cytokines. Methods 70 elderly PSD patients admitted to the Xuzhou Municipal Hospital affiliated with Xuzhou Medical University from June 2022 to December 2024 were selected as study objects. Patients were randomly divided into control group treated with sertraline and study group treated with aerobic exercise combined with sertraline. The treatment duration was 8 weeks. The Hamilton Depression Rating Scale (HAMD) scores, the clinical efficacy, cognitive function [Mini Mental State Examination (MMSE)], and the levels of inflammatory cytokines (IL-1β, IL-6, TNF-α) were compared before and after treatment. Results No significant differences in baseline data were observed between the two groups before treatment. After 4 and 8 weeks of treatment, HAMD scores were significantly decreased compared to baseline in both groups (all P<0.05). The study group showed significantly lower HAMD scores than the control group at both 4 and 8 weeks (all P<0.05). The overall clinical effective rate was significantly higher in the study group (94.29%) than in the control group (77.14%)(P<0.05). MMSE scores were significantly increased compared to baseline in both groups at 4 and 8 weeks(all P<0.05), and the study group demonstrated significantly higher MMSE scores than the control group at both time points (all P<0.05). Similarly, serum levels of IL-1β, IL-6, and TNF-α were significantly reduced from baseline in both groups at 4 and 8 weeks (all P<0.05). The reductions in these inflammatory cytokine levels were significantly greater in the study group compared to the control group (all P<0.05). The incidence of adverse reactions was 8.57% in the control group and 5.71% in the study group, with no statistically significant difference (P>0.05). Conclusion The combination of aerobic exercise and sertraline is a safe and reliable therapeutic strategy for elderly PSD patients, alleviating depressive symptoms, improving cognitive function, and reducing systemic inflammation.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202504044
Abstract:
Objective To investigate the efficacy and safety of EGFR-TKIs monotherapy and its combination therapy in the first-line treatment of advanced non-small cell lung cancer(NSCLC)patients with EGFR mutations. Methods Databases such as PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were systematically searched to collect eligible phase II/III randomized controlled trials (RCTs), with the time range from the establishment of the databases to June 2023. Two researchers independently screened the literature, extracted data, and assessed the risk of bias in the studies. Outcome data, including overall survival (OS), progression-free survival (PFS), objective response rate (ORR), grade 3 or higher adverse events (≥3 AEs), and serious adverse events (SAEs), were collected. A network meta-analysis was performed using R software (version 4.2.1) under the Bayesian theoretical framework. Subgroup analyses of survival outcomes (OS, PFS) were conducted based on different clinical and pathophysiological characteristics of the patients. Results A total of t wenty-eight phase II/III RCTs were included in the study, involving a total of 7 460 patients and 18 first-line treatment regimens. The results showed that in terms of efficacy, gefitinib + pemetrexed-containing chemotherapy performed best in OS and ORR, while osimertinib + bevacizumab performed best in PFS. In terms of safety, furmonertinib had the lowest incidence of ≥3 grade AEs, and osimertinib had the lowest incidence of SAEs. Subgroup analysis results indicated that the efficacy and safety of various treatment regimens differed among patients with different clinical and pathological characteristics. Conclusion Monotherapy with third-generation EGFR-TKIs, represented by osimertinib, serves as the preferred therapeutic option considering both efficacy and safety profiles. While some combination therapies can enhance survival benefits, but need to be vigilant about increased toxicity. Clinical decision-making should be tailored based on patient' mutation subtypes, comorbidities, and tolerance.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.20240380
Abstract:
This study aimed to clarify the causal relationship between meaning in life and depression symptoms, explore the evolutionary patterns of meaning in life, and assess its impact on the incidence of depressive symptoms. A two-wave longitudinal study with a 12-month interval was conducted among 896 university students recruited from one university. The meaning in life questionnaire and the depression symptom screening questionnaire were administered. The findings showed that: 1)Meaning in life at T1 negatively predicted depression symptoms at T2. Conversely, depression symptoms at T1 did not significantly predict meaning in life at T2. 2)The evolutionary patterns of meaning in life from T1 to T2 could be categorized into four groups: sustained low meaning, meaning improvement, meaning reduction, and sustained high meaning. The incidence of depressive symptoms in these four groups was 13.00%, 5.00%, 12.00%, and 4.00%, respectively. 3)The evolutionary patterns of meaning in life significantly impacted the incidence of depressive symptoms. Compared to the sustained high meaning group, both the sustained low meaning group and the meaning reduction group exhibited significantly higher rates of depression symptoms. The results suggest that psychological health education in universities should focus on individuals with sustained low meaning or meaning reduction, and that enhancing meaning in life serves as an effective intervention approach to reducing the incidence of depression symptoms among university students.
This study aimed to clarify the causal relationship between meaning in life and depression symptoms, explore the evolutionary patterns of meaning in life, and assess its impact on the incidence of depressive symptoms. A two-wave longitudinal study with a 12-month interval was conducted among 896 university students recruited from one university. The meaning in life questionnaire and the depression symptom screening questionnaire were administered. The findings showed that: 1)Meaning in life at T1 negatively predicted depression symptoms at T2. Conversely, depression symptoms at T1 did not significantly predict meaning in life at T2. 2)The evolutionary patterns of meaning in life from T1 to T2 could be categorized into four groups: sustained low meaning, meaning improvement, meaning reduction, and sustained high meaning. The incidence of depressive symptoms in these four groups was 13.00%, 5.00%, 12.00%, and 4.00%, respectively. 3)The evolutionary patterns of meaning in life significantly impacted the incidence of depressive symptoms. Compared to the sustained high meaning group, both the sustained low meaning group and the meaning reduction group exhibited significantly higher rates of depression symptoms. The results suggest that psychological health education in universities should focus on individuals with sustained low meaning or meaning reduction, and that enhancing meaning in life serves as an effective intervention approach to reducing the incidence of depression symptoms among university students.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.202406029
Abstract:
Objective To investigate the preventive and therapeutic effects of ethanol extracts derived from three sources of traditional Chinese medicine: Stellera chamaejasme L., Euphorbia fischeriana Steud., and Euphorbia kansuensis Prokh., on imiquimod (IMQ)-induced psoriasis in mice. Methods Thirty-six male BALB/c mice were randomly divided into the following 6 groups with 6 mice in each group: blank control, model, Stellera chamaejasme, Euphorbia fischeriana, Euphorbia kansuensis, and calcipotriol. PASI (Psoriasis Area and Severity Index) scores were used to record the changes of skin lesions in each group; HE (hematoxylin-eosin) staining was used to observe the pathological morphology of skin and measure the thickness of the epidermis. Immunohistochemistry was used to detect the expression of nuclear antigen Ki67 in the skin tissues of mice. Results Compared with the model group, the three kinds of ethanol extracts can reduce the PASI score, inhibit epidermal thickening, and decrease expression of Ki67 in the psoriasis mice. Among them, the therapeutic effect of Stellera chamaejasme was the most significant and it was better than the commonly used topical drug calcipotriol. Conclusion The ethanol extract of Stellera chamaejasme has good anti-psoriatic activity, can inhibit the abnormal proliferation of keratinocytes, can reduce the expression of Ki67, and can significantly improve psoriasis-like skin lesions.
Accepted Manuscript
, Available online
doi: 10.12206/j.issn.2097-2024.
Abstract:
currentMore>
Display Method:
2026, 44(8): 383-388, 425.
doi: 10.12206/j.issn.2097-2024.202411043
Abstract:
Oxidative stress is an important pathophysiological pathway for the development and progression of ferroptosis. Under pathological conditions, the production of a large amount of reactive oxygen species (ROS) exceeds the buffering capacity of the antioxidant defense system, resulting in lipid peroxidation and cell ferroptosis in the state of oxidative stress. Cellular lipid peroxidation can generate toxic aldehydes, which interact with important biological macromolecules and break the normal function of cells. At present, it has been found that aldehyde dehydrogenase 2 (ALDH2) can eliminate these aldehydes and regulate the cycle of toxic aldehydes-ROS-oxidative stress-lipid peroxidation, thereby improving the prognosis of diseases associated with iron death. Ferroptosis and ALDH2 were introduced, and the current researches on ALDH2 were summarized to improve diseases associated with iron death, which can open up new directions for the subsequent research on the treatment of diseases associated with iron death.
Oxidative stress is an important pathophysiological pathway for the development and progression of ferroptosis. Under pathological conditions, the production of a large amount of reactive oxygen species (ROS) exceeds the buffering capacity of the antioxidant defense system, resulting in lipid peroxidation and cell ferroptosis in the state of oxidative stress. Cellular lipid peroxidation can generate toxic aldehydes, which interact with important biological macromolecules and break the normal function of cells. At present, it has been found that aldehyde dehydrogenase 2 (ALDH2) can eliminate these aldehydes and regulate the cycle of toxic aldehydes-ROS-oxidative stress-lipid peroxidation, thereby improving the prognosis of diseases associated with iron death. Ferroptosis and ALDH2 were introduced, and the current researches on ALDH2 were summarized to improve diseases associated with iron death, which can open up new directions for the subsequent research on the treatment of diseases associated with iron death.
2026, 44(8): 389-394.
doi: 10.12206/j.issn.2097-2024.202509037
Abstract:
Oral vaccines, owing to their non-invasive nature, ease of administration, and ability to elicit both mucosal and systemic immune responses, represent a pivotal direction in vaccine development. Microfold cells (M cells), a specialized subset of immune-surveillance epithelial cells, though sparsely distributed, possess exceptional capacity for antigen uptake and transcytosis, rendering them a critical target for overcoming the bottlenecks of oral vaccine delivery. The morphological structure, antigen uptake mechanisms, and surface receptor characteristics of intestinal M cells were summarized in this paper. The multifaceted challenges currently impeding M cell-targeted oral delivery and recent advances in targeting strategies based on receptor–ligand specific recognition were analyzed. The design and application of delivery carriers tailored for M cell targeting were reviewed, which aimed to provide insights and guidance for future research and development of M cell-targeted mucosal delivery systems in the intestine.
Oral vaccines, owing to their non-invasive nature, ease of administration, and ability to elicit both mucosal and systemic immune responses, represent a pivotal direction in vaccine development. Microfold cells (M cells), a specialized subset of immune-surveillance epithelial cells, though sparsely distributed, possess exceptional capacity for antigen uptake and transcytosis, rendering them a critical target for overcoming the bottlenecks of oral vaccine delivery. The morphological structure, antigen uptake mechanisms, and surface receptor characteristics of intestinal M cells were summarized in this paper. The multifaceted challenges currently impeding M cell-targeted oral delivery and recent advances in targeting strategies based on receptor–ligand specific recognition were analyzed. The design and application of delivery carriers tailored for M cell targeting were reviewed, which aimed to provide insights and guidance for future research and development of M cell-targeted mucosal delivery systems in the intestine.
2026, 44(8): 395-399, 407.
doi: 10.12206/j.issn.2097-2024.202412058
Abstract:
Perilla leaf volatile oil is rich in monoterpenes, aromatic compounds, and other active constituents, with perillaldehyde as its characteristic marker, exhibiting a wide range of pharmacological activities including antibacterial, anti-inflammatory, and antitumor effects. In recent years, systematic studies have been conducted on its chemical composition and pharmacodynamic basis. The methods for content determination have become increasingly sophisticated, with gas chromatography-mass spectrometry (GC-MS) and other techniques being widely applied for comparative analysis of samples from different sources; however, the results are influenced by multiple factors such as germplasm variation, growth stage, and extraction process. Regarding the biosynthetic pathway, key enzyme genes involved in the mevalonate and shikimate pathways are being progressively elucidated. In terms of bioactivity, in vivo and in vitro experiments have confirmed that its volatile oil components exert synergistic effects through multi-target mechanisms, with applications extended to food preservation, flavor and fragrance industry, and pharmaceutical field. The research progress on the biosynthesis, content determination, and bioactivities of volatile oil components from perilla leaves was reviewed, aiming to further clarify the active material basis and mechanisms of action, and to provide a reference for more in-depth exploration and utilization of the medicinal and edible value of Perilla frutescens.
Perilla leaf volatile oil is rich in monoterpenes, aromatic compounds, and other active constituents, with perillaldehyde as its characteristic marker, exhibiting a wide range of pharmacological activities including antibacterial, anti-inflammatory, and antitumor effects. In recent years, systematic studies have been conducted on its chemical composition and pharmacodynamic basis. The methods for content determination have become increasingly sophisticated, with gas chromatography-mass spectrometry (GC-MS) and other techniques being widely applied for comparative analysis of samples from different sources; however, the results are influenced by multiple factors such as germplasm variation, growth stage, and extraction process. Regarding the biosynthetic pathway, key enzyme genes involved in the mevalonate and shikimate pathways are being progressively elucidated. In terms of bioactivity, in vivo and in vitro experiments have confirmed that its volatile oil components exert synergistic effects through multi-target mechanisms, with applications extended to food preservation, flavor and fragrance industry, and pharmaceutical field. The research progress on the biosynthesis, content determination, and bioactivities of volatile oil components from perilla leaves was reviewed, aiming to further clarify the active material basis and mechanisms of action, and to provide a reference for more in-depth exploration and utilization of the medicinal and edible value of Perilla frutescens.
2026, 44(8): 400-407.
doi: 10.12206/j.issn.2097-2024.202409045
Abstract:
Objective To investigate the effect of activating α7 nicotinic acetylcholine receptor (α7nAChR) on calcium chloride (CaCl2)-induced abdominal aortic aneurysm (AAA) injury in mice. Methods AAA model was induced by CaCl2 in wild type (WT) mice and α7nAChR knockout (α7nAChR−/−) mice. The effects of knockout of α7nAChR on histological damage in CaCl2-induced AAA mice and expression of inflammatory factors were assessed by HE staining, Elasticavan Gieson (EVG) staining and IHC staining. Rat-derived primary vascular smooth muscle cells (VSMC) were stimulated with tumor necrosis factor-α (TNF-α), which mimicked the inflammatory environment of AAA. The expressions of inflammation-related proteins were detected by using Western-blot (WB) with or without PNU-282987 to activate α7nAChR. Results Aortic dilatation was obvious, and the aortic structure was disrupted in CaCl2-induced AAA mice. Knockout of α7nAChR further exacerbated the histological injury and significantly up-regulated the expression of inflammation-related proteins in aorta of AAA mice. It was showed that TNF-α stimulation of VSMC increased inflammation-related protein expression, whereas activation of α7nAChR prevented the phenomenon. Conclusion Activation of α7nAChR could attenuate CaCl2-induced AAA injury in mice by suppressing the inflammatory response.
2026, 44(8): 408-416, 430.
doi: 10.12206/j.issn.2097-2024.202405056
Abstract:
Objective To explore the mechanism of Shen Hong capsule in preventing and treating acute mountain sickness based on biological information platform and in vitro experiment. Methods Traditional Chinese Medicine Systems Pharmacology (TCMSP) and Traditional Chinese Medicine Information Database (TCMID) were used to obtain the active components and predicted targets of Shen Hong capsule. Therapeutic Target Database (TTD), Disease Gene Network (DisGeNET) database and GeneCards database were used to search for the targets of acute mountain sickness related diseases, and the potential therapeutic targets were obtained. The protein-protein interaction (PPI) was analyzed by Search Tool for the Retrieval of Interacting Genes/Proteins (STRING), the Database for Annotation, Visualization, and Integrated Discovery (DAVID) online platform was used to analyse the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) signal pathway enrichment. The network information was visualized by Cytoscape software, the key targets in PPI network were obtained according to the topology data, and the binding ability of main active components and key therapeutic targets were analyzed by molecular docking. The validation of the main active components was performed by liquid chromatography-mass spectrometry (LC-MS). The hypoxia model was created by H9c2 cells, apoptosis was visualized by Hoechst33342 staining, and key target proteins were verified by Western blot. Results 91 active components, 3 main active components and 150 predicted targets were selected from Shen Hong capsule. 515 targets of altitude sickness-related diseases and 37 targets of Shen Hong capsule regulating altitude sickness-related diseases were screened out. 44 related signal pathways, such as HIF-1 signal pathway, PPAR signal pathway, drug metabolism - cytochrome P450, were enriched and analyzed. TNF, IL1B, VEGFA, NOS3, EGFR, ESR1, PPARG, NR3C1, HMOX1 and IFNG were 10 key targets. The molecular docking results showed that the docking conformations between the main active components and the key targets were stable. The three main active components of quercetin, luteolin and kaempferol were identified by LC-MS, and in vitro experiments proved that Shen Hong capsule could relieve acute hypoxia injury by regulating the expression of HIF-1α, PPARG, NOS3, and TNF. Conclusion Shen Hong capsule could regulate the body’s hypoxia response and metabolism through multi-component, multi-target and multi-channel ways, so as to prevent and treat acute mountain sickness. This study provided a direction for further exploring the mechanism of Shen Hong capsule, and also provided a theoretical basis for further development and clinical application.
2026, 44(8): 417-425.
doi: 10.12206/j.issn.2097-2024.202412022
Abstract:
Objective To investigate the potential protective mechanism of tanshinone ⅡA against acetaminophen (APAP)-induced acute liver injury. Methods Thirty mice were randomly divided into the normal group, model group, low-dose tanshinone ⅡA group (5 mg/kg), medium-dose tanshinone ⅡA group (10 mg/kg) and high-dose tanshinone ⅡA group (20 mg/kg). All groups were intragastrically administered once daily for 7 consecutive days. On the 7th day, except for the normal group, mice in the remaining groups were intraperitoneally injected with 400 mg/kg APAP to establish the acute lung injury (ALI) model. The protective effect of tanshinone ⅡA was evaluated based on the liver weight ratio, the levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and HE staining. Targets of tanshinone ⅡA were predicted by the Traditional Chinese Medicine Systems Pharmacology (TCMSP), and a shared target protein-protein interaction (PPI) network was constructed by Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) 11.5 in combination with disease targets from GeneCards. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was performed by Database for Annotation, Visualization and Integrated Discovery (DAVID), and the component-target-pathway network was constructed. The molecular docking between tanshinone ⅡA and the core targets was performed by AutoDock and visualised. Results Compared with the normal group, the liver weight ratio and serum aminotransferase level of mice with acute liver injury were significantly elevated (P<0.05), and the pathological injury of liver tissue was obvious. After tanshinone ⅡA treatment, the above index were significantly reduced (P<0.05), and the pathological injury was significantly improved. Further network pharmacological analysis was carried out and found that KEGG pathway enrichment analysis focused on IL-17 signaling pathway and tumor necrosis factor (TNF) signaling pathway, etc. In addition, the PPI core network showed that the key targets of tanshinone ⅡA to ameliorate acute liver injury mainly included TP53, AKT1, SRC, TNF and JUN. The molecular docking results showed that tanshinone ⅡA had high binding scores with the targets of MMP9, NFKB1, TNF, EP300 and SMAD3; and was able to bind to the targets of TP53, AKT1, SRC and JUN. Conclusion Tanshinone ⅡA may play a protective role against acute liver injury by regulating genes such as AKT1, JUN and TNF, and participating in signaling pathways such as TNF and IL-17.
2026, 44(8): 426-430.
doi: 10.12206/j.issn.2097-2024.202411036
Abstract:
Objective To evaluate the effect of remimazolam premedication on emergence delirium (ED) in children undergoing tonsillectomy and/or adenoidectomy. Methods Children aged 3-6 years who underwent tonsillectomy and/or adenoidectomy with general anesthesia in Zhongshan Hospital Affiliated to Xiamen University from July 2023 to September 2024 were randomly divided into 0.1 mg/kg remimazolam group (group R1), 0.2 mg/kg remimazolam group group R2) and normal saline group (group P). Three groups were sedated preoperatively with remimazolam 0.1 mg/kg, remimazolam 0.2 mg/kg and normal saline, respectively. The primary outcome was the incidence of ED. The secondary outcomes included the parental separation anxiety scale (PSAS) score when entering the operating room, the induction compliance checklist (ICC) score at induction, the anesthetic recovery time, the incidence of rescue propofol for ED, the face, legs, activity, cry, and consolability (FLACC) score and the incidence of postoperative pain during the recovery period, the incidence of adverse reactions during the operation and postoperatively, and the incidence of negative postoperative behavioral changes (NPOBCs) at first day, 7th day, 30th day postoperatively. Results A total of 119 children completed the study, including 41 children in group R1, 38 children in group R2, and 40 children ingroup P. The incidence of ED and propofol rescue, the PSAS scores and ICC scores of group R1 and R2 were lower than that of group P (P<0.05), and the above results in group R2 was better than those in group R1 (P<0.05). The FLACC score, the incidence of postoperative pain, and the incidence of adverse reactions among the three groups had no difference (P>0.05). The incidence of NPOBCs at 1st day and 7th day postoperatively in group R1 and group R2 was lower than that in group P (P<0.05), but no difference was detected at 30th day postoperatively among the three groups (P>0.05). Conclusion Remimazolam used for preoperative sedation could reduce the incidence of ED in children undergoing tonsillectomy and/or adenoidectomy, and had a positive effect on alleviating the preoperative anxiety and preventing NPOBCs.
2026, 44(8): 431-436.
doi: 10.12206/j.issn.2097-2024.202601017
Abstract:
Objective To evaluate the cost-utility of risdiplam in the treatment of pediatric spinal muscular atrophy (SMA) and analyze changes in patients’ out-of-pocket economic burden under the medical insurance scenarios. Methods A Markov model was developed from the healthcare system perspective to compare the long-term costs and quality-adjusted life years (QALYs) of risdiplam treatment versus conventional therapy. The incremental cost-utility ratio (ICUR) was calculated. One-way sensitivity analysis and probabilistic sensitivity analysis were conducted to assess the robustness of the model. On this basis, health insurance scenarios were simulated to evaluate patients’ individual economic burden. Results Base-case analysis showed that risdiplam treatment generated additional health benefits but substantially increased medical costs. The resulting ICUR did not demonstrate a clear cost-utility advantage under the current willingness-to-pay threshold. Sensitivity analyses indicated that the model results were relatively robust, with drug costs and key utility parameters being the main drivers of economic outcomes. Health insurance scenario analysis demonstrated that increasing reimbursement levels and reducing patient copayment rates could significantly alleviate patients’ financial burden. Conclusion Risdiplam for pediatric SMA faces economic challenges under the current health insurance payment framework in China. However, optimizing health insurance reimbursement policies and developing multi-tiered healthcare security mechanisms may improve its affordability and accessibility.
过刊浏览
- 2026 7 6 5 4 3 2 1
- 2025 12 11 10 9 8 7 6 5 4 3 2 1
- 2024 12 11 10 9 8 7 6 5 4 3 2 1
- 2023 12 11 10 9 8 7 6 5 4 3 2 1
- 2022 6 5 4 3 2 1
- 2021 6 5 4 3 2 1
- 2020 6 5 4 3 2 1
- 2019 6 5 4 3 2 1
- 2018 6 5 4 3 2 1
- 2017 6 5 4 3 2 1
- 2016 6 5 4 3 2 1
- 2015 6 5 4 3 2 1
- 2014 6 5 4 3 2 1
- 2013 6 5 4 3 2 1
- 2012 6 5 4 3 2 1
- 2011 6 5 4 3 2 1
- 2010 6 5 4 3 2 1
- 2009 6 5 4 3 2 1
- 2008 6 5 4 3 2 1
- 2007 6 5 4 3 2 1
- 2006 6 5 4 3 2 1
- 2005 6 5 4 3 2 1
- 2004 6 5 4 3 2 1
- 2003 6 5 4 3 2 1
- 2002 6 5 4 3 2 1
- 2001 6 5 4 3 2 1
- 2000 6 5 4 3 2 1
- 1999 6 5 4 3 2 1
- 1998 6 5 4 3 2 1
- 1997 6 5 4 3 2 1
- 1996 6 5 4 3 2 1
- 1995 6 5 4 3 2 1
- 1994 4 3 2 1
- 1993 4 3 2 1
- 1992 4 3 2 1
- 1991 4 3 2 1
- 1990 4 3 2 1
- 1989 4 3 2 1
- 1988 4 3 2 1
- 1987 4 3 2 1
- 1986 4 3 2 1
- 1985 4 3 2 1
- 1984 4 3 2 1
- 1983 3 2 1
Chief Editor: LI Jie Wei
Publication Number:
ISSN 2097-2024
CN 31-2185/R
Website: www.yxsjzz.cn or yxsj.smmu.edu.cn
Email: yxsjzzs@163.com
NewsMore >
Top View
Top Down
- 1The latest research progress of α7 nicotinic acetylcholine receptor in cholinergic anti-inflammatory pathway
- 2Research progress on action mechanism and clinical application of hyaluronic acid
- 3Research progresses on Keap1-Nrf2 pathway in inflammatory diseases
- 4Research progress and coping strategy of the drug resistant mechanism of platinum anti-tumor drugs
- 5Research progress on Sophora Flavescens of traditional Chinese medicine
- 6Advances in mosquito repellents
- 7Progress on mRNA tumor vaccine with non-viral delivery system
- 8Molecular mechanism of Shenling Baizhu powder in treatment of cancer cachexia based on network pharmacology
- 9Review of pharmacological effects of Paeoniae Radix Rubra
- 10Research progress on the treatment of vascular dementia by promoting blood circulation and removing blood stasis
- More >
Wechat
Contribution System
Author Login
Review Login
Editor Login
Reader Login



友情链接